Trade

with

Female Health Co
(NASDAQ: FHCO)
AdChoices
4.18
+0.07
+1.70%
After Hours :
4.18
0.00
0.00%

Open

4.15

Previous Close

4.11

Volume (Avg)

91.97k (214.18k)

Day's Range

4.07-4.21

52Wk Range

3.31-9.95

Market Cap.

120.74M

Dividend Rate (Yield )

0.28 (5.02%)

Beta

0.99

Shares Outstanding

28.89M

P/E Ratio (EPS)

12.56 (0.33)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Household & Personal Products
Highlights
Analyst Recommendation: Not Available
    • Revenue

    • 31.46M

    • Net Income

    • 14.34M

    • Market Cap.

    • 120.74M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 40.42

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.99

    • Forward P/E

    • -

    • Price/Sales

    • 5.08

    • Price/Book Value

    • 4.17

    • Price/Cash flow

    • 238.10

      • EBITDA

      • 10.35M

      • Return on Capital %

      • 29.71

      • Return on Equity %

      • 34.43

      • Return on Assets %

      • 29.71

      • Book Value/Share

      • 1.00

      • Shares Outstanding

      • 28.89M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.07 (4/28/2014)

      • Dividend Declaration Date

      • 3/24/2014

      Analyst Recommendation
      -
      Not Available
        • 1 Year Price Target

        • -

        • Credit Rating

        • -

        • Analysts

        • 0

        • EPS Estimate

        • -

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 8.50

          • -6.69

          • Net Income

            YTD/YTD (last year)

          • -6.30

          • -4.13

          • Net Income

            Q/Q (last year)

          • 59.50

          • 31.38

          • Sales (Revenue)

            5-Year Annual Average

          • 4.18

          • 1.07

          • Net Income

            5-Year Annual Average

          • 23.60

          • -9.81

          • Dividends

            5-Year Annual Average

          • -

          • -10.65

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 52.73

            • 49.25

            • Pre-Tax Margin

            • 25.98

            • 17.71

            • Net Profit Margin

            • 40.42

            • 13.30

            • Average Gross Margin

              5-Year Annual Average

            • 55.00

            • 50.34

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 23.40

            • 17.70

            • Average Net Profit Margin

              5-Year Annual Average

            • 34.40

            • 705.41B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.38

              • Current Ratio

              • 4.34

              • 0.86

              • Quick Ratio

              • 2.85

              • 0.52

              • Interest Coverage

              • -

              • 20.99

              • Leverage Ratio

              • 1.13

              • 2.49

              • Book Value/Share

              • 1.00

              • 10.30

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 12.79

                • 20.37

                • P/E Ratio 5-Year High

                • 30.70

                • 188.08

                • P/E Ratio 5-Year Low

                • 9.95

                • 42.30

                • Price/Sales Ratio

                • 5.17

                • 2.15

                • Price/Book Value

                • 4.24

                • 5.21

                • Price/Cash Flow Ratio

                • 238.10

                • 15.82

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 34.43

                    (52.50)

                  • 17.98

                    (18.65)

                  • Return on Assets %

                    (5-Year Average)

                  • 29.71

                    (42.00)

                  • 8.23

                    (8.59)

                  • Return on Capital %

                    (5-Year Average)

                  • 34.43

                    (52.40)

                  • 11.58

                    (12.08)

                  • Income/Employee

                  • 71.56k

                  • 49.06k

                  • Inventory Turnover

                  • 3.84

                  • 5.84

                  • Asset Turnover

                  • 0.74

                  • 0.62

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  9.79M
                  Operating Margin
                  31.12
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  238.10
                  Ownership

                  Institutional Ownership

                  40.96%

                  Top 10 Institutions

                  31.44%

                  Mutual Fund Ownership

                  10.89%

                  Float

                  61.78%

                  5% / Insider Ownership

                  14.97%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Royce Value Plus Fund

                  •  

                    506,000

                  • -8.99

                  • 1.75

                  • Vanguard Total Stock Mkt Idx

                  •  

                    415,043

                  • 0.00

                  • 1.44

                  • iShares Russell 2000 (AU)

                  •  

                    320,770

                  • -1.46

                  • 1.31

                  • Crawford Dividend Opportunity Fund

                  •  

                    243,882

                  • -5.21

                  • 0.84

                  • Vanguard Extended Market Index Fund

                  •  

                    192,658

                  • 0.00

                  • 0.67

                  • Manulife Global All Cap Focused Fund

                  •  

                    184,517

                  • -15.61

                  • 0.64

                  • iShares Russell 2000 Growth

                  •  

                    105,491

                  • 0.34

                  • 0.43

                  • Manulife Value Balanced Fund

                  •  

                    104,387

                  • -16.78

                  • 0.36

                  • CREF Stock

                  •  

                    69,377

                  • 0.00

                  • 0.24

                  • TCW Small Cap Growth CIT

                  •  

                    64,700

                  • 14.72

                  • 0.23

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Duke University

                  •  

                    1,748,457

                  • -18.74%

                  • 6.09

                  • DePrince, Race & Zollo, Inc.

                  •  

                    1,117,916

                  • +1,276.12%

                  • 3.87

                  • Vanguard Group, Inc.

                  •  

                    680,632

                  • +13.91%

                  • 2.36

                  • Renaissance Technologies Corp

                  •  

                    559,102

                  • -10.81%

                  • 1.94

                  • Royce & Associates, LLC

                  •  

                    556,000

                  • -21.71%

                  • 1.93

                  • BlackRock Fund Advisors

                  •  

                    538,963

                  • -12.74%

                  • 1.87

                  • Manufacturers Life Insurance Co

                  •  

                    337,186

                  • +106.52%

                  • 1.17

                  • Crawford Investment Counsel, Inc

                  •  

                    318,382

                  • +12.98%

                  • 1.10

                  Company Profile

                  Sector

                  Consumer Defensive

                  Industry

                  Household & Personal Products

                  Type

                  High Yield

                  Style

                  Small Core

                  Female Health Co was incorporated in Wisconsin in 1971. The Company is engaged in development, manufacture and marketing of consumer health care products. The Company is engaged in the marketing, manufacture and distribution of a con...moresumer health care product, the FC2 female condom. FC2 is the only currently available female-controlled product, approved by the U.S. Food and Drug Administration (FDA) and cleared by the World Health Organization for purchase by U.N. agencies, that provides dual protection against unintended pregnancy and sexually transmitted infections ("STIs"), including HIV/AIDS. The raw material used to produce FC2 is a nitrile polymer. Its main market is public health sector. The principal raw material used to produce FC2 is a nitrile polymer. The Company's FC2 female condom partic...moreipates in the same market as male condoms but is not seen as directly competing with male condoms. FC2 is subject to regulation by the FDA under the Food, Drug and Cosmetic Act, and by foreign regulatory agencies.lessless

                  Key People

                  Karen King

                  President/CEO/Director

                  O.B. Parrish

                  Chairman of the Board/Director

                  Ms. Michele Greco

                  CFO/Chief Accounting Officer/Vice President

                  Mr. Martin Tayler

                  Executive VP, Divisional

                  David R. Bethune

                  Director

                  • Female Health Co

                  • 515 N. State Street

                  • Chicago, IL 60654

                  • USA.Map

                  • Phone: +1 312 595-9123

                  • Fax: +1 312 595-9122

                  • femalehealth.com

                  Incorporated

                  1971

                  Employees

                  134

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: